MGWM
ELAN icon

Marks Group Wealth Management’s Elanco Animal Health ELAN Stock Holding History

Marks Group Wealth Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-72,407
Closed -$1.62M – 243
2020
Q1 		$1.62M Buy
72,407
+6,769
+10% +$185K 0.42% 98
2019
Q4 		$1.93M Buy
+65,638
New +$1.78M 0.38% 107

Other funds holding ELAN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Marks Group Wealth Management's ELAN Position: Q2 2020 in Review

Marks Group Wealth Management sold out of Elanco Animal Health (ELAN) in Q2 2020, closing a stake of 72,407 shares — an estimated $1.62M sold.

Marks Group Wealth Management first reported a position in ELAN in Q4 2019 and held it in 2 quarters. The position peaked at $1.93M in Q4 2019. 372 funds tracked by Wall St. Rank hold ELAN as of Q2 2020.

  • Marks Group Wealth Management reported no remaining Elanco Animal Health position as of Q2 2020 after selling out during the quarter.
  • Marks Group Wealth Management sold 72,407 Elanco Animal Health shares in Q2 2020, an estimated $1.62M.
  • Marks Group Wealth Management first reported a position in Elanco Animal Health in Q4 2019 and held it in 2 quarters.
  • Marks Group Wealth Management's Elanco Animal Health position peaked at $1.93M in Q4 2019.
  • 372 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2020.

Based on Marks Group Wealth Management's 13F filing for Q2 2020, filed 10 Aug 2020.